Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

RoActemra®

Known as: RoActemra 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Tocilizumab (Actemra, RoActemra)
Tocilizumab (Actemra) is a drug used to treat autoimmune diseases, including rheumatoid arthritis, through a novel mechanism of… Expand
Is this relevant?
2018
2018
Differential role of Interleukin-1 and Interleukin-6 in K-Ras-driven pancreatic carcinoma undergoing mesenchymal transition.
K-Ras mutations are a hallmark of human pancreatic adenocarcinoma (PDAC) and epithelial-mesenchymal-transition (EMT) is a driver… Expand
Is this relevant?
2018
2018
A Case of Adult-Onset Still’s Disease Caused by a Novel Splicing Mutation in TNFAIP3 Successfully Treated With Tocilizumab
TNFAIP3 encodes the NF-κB regulatory protein A20. High-penetrance heterozygous mutations in TNFAIP3 cause a haploinsufficiency of… Expand
Is this relevant?
2017
2017
Anti-carbamylated protein antibodies precede disease onset in monkeys with collagen-induced arthritis
BackgroundRheumatoid factor (RF), anti-citrullinated protein antibodies (ACPA) and anti-carbamylated protein (anti-CarP… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?
Review
2016
Review
2016
The clinical effectiveness and cost-effectiveness of abatacept, adalimumab, etanercept and tocilizumab for treating juvenile idiopathic arthritis: a systematic review and economic evaluation.
BACKGROUND Juvenile idiopathic arthritis (JIA) is characterised by joint pain, swelling and a limitation of movement caused by… Expand
  • table 1
  • table 2
  • table 4
  • table 5
  • table 6
Is this relevant?
2013
2013
FRI0323 Prospective Follow-Up of Tocilizumab Treatment in 1503 Patients with Refractory Rheumatoid Arthritis: Tolerance Data at 1 Year from the French Registry Regate (Registry – Roactemra)
Objectives To assess tolerance and safety of rheumatoid arthritis (RA) treatment by tocilizumab (TCZ) in real life Methods The… Expand
Is this relevant?
Review
2013
Review
2013
A review of cost-effectiveness evaluations as part of national health technology assessments of biologic DMARDs in the treatment of rheumatoid arthritis.
Rheumatoid arthritis (RA) is an autoimmune chronic disease which is associated with an increasing disability in patients and high… Expand
  • figure 1
Is this relevant?
Highly Cited
2012
Highly Cited
2012
Is tocilizumab an effective option for treatment of refractory uveitis associated with juvenile idiopathic arthritis?
To the Editor: Anti-interleukin 6 receptor (anti-IL-6R) antibodies have been effective in experimental models of autoimmune… Expand
Is this relevant?
Review
2011
Review
2011
Tocilizumab: A Novel Humanized Anti-Interleukin 6 Receptor Antibody for the Treatment of Patients with Rheumatoid Arthritis
  • Rieke Alten
  • Therapeutic advances in musculoskeletal disease
  • 2011
    • Corpus ID: 8591212
Tocilizumab (TCZ; RoActemra® or Actemra®) is a recombinant humanized monoclonal antibody that acts as an interleukin 6 (IL-6… Expand
  • table 1
  • table 2
  • figure 1
  • table 8
  • table 7
Is this relevant?
Review
2010
Review
2010
Tocilizumab for rheumatoid arthritis.
Tocilizumab (RoActemra-Roche) is a new biological agent available in the UK for the treatment of adults with rheumatoid arthritis… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE